SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS - Draft Registration Statement:
SEC Accession No. 0000912057-15-000069
Filing Date
2015-03-24
Accepted
2015-03-24 17:19:53
Documents
15

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 1255338
2 filename2.htm EX-3.1 8114
3 filename3.htm EX-3.2 48388
4 filename4.htm EX-3.3 360621
5 filename5.htm EX-21.1 3272
6 GRAPHIC g48513.jpg GRAPHIC 16887
7 GRAPHIC g63362kei001.jpg GRAPHIC 3318
8 GRAPHIC g63362kei002.jpg GRAPHIC 9008
9 GRAPHIC g63362kgi001.jpg GRAPHIC 4888
10 GRAPHIC g83535.jpg GRAPHIC 34293
11 GRAPHIC g202978.jpg GRAPHIC 77495
12 GRAPHIC g330156.jpg GRAPHIC 45720
13 GRAPHIC g580431.jpg GRAPHIC 35258
14 GRAPHIC g843129.jpg GRAPHIC 120002
15 GRAPHIC g879833.jpg GRAPHIC 13251
  Complete submission text file 0000912057-15-000069.txt   2174532
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 441-532-8833
Roivant Neurosciences Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0315
Type: DRS | Act: 33 | File No.: 377-00961 | Film No.: 15722564
SIC: 2834 Pharmaceutical Preparations